112 related articles for article (PubMed ID: 11060540)
1. Protein C deficiency related to valproic acid therapy: a possible association with childhood stroke.
Gruppo R; Degrauw A; Fogelson H; Glauser T; Balasa V; Gartside P
J Pediatr; 2000 Nov; 137(5):714-8. PubMed ID: 11060540
[TBL] [Abstract][Full Text] [Related]
2. Protein C, protein S and other pro- and anticoagulant activities among epileptic children using sodium valproate.
Ugras M; Yakinci C
Brain Dev; 2006 Oct; 28(9):549-53. PubMed ID: 16842952
[TBL] [Abstract][Full Text] [Related]
3. Thrombophilic risk factors in epileptic children treated with valproic Acid.
Unal O; Deda G; Teber S; Ertem M; Akar N
Pediatr Neurol; 2009 Feb; 40(2):102-6. PubMed ID: 19135623
[TBL] [Abstract][Full Text] [Related]
4. Decreased platelet count in children with epilepsy treated with valproate and its relationship to the immature platelet fraction.
Kurahashi H; Takami A; Murotani K; Numoto S; Okumura A
Int J Hematol; 2018 Jan; 107(1):105-111. PubMed ID: 28879549
[TBL] [Abstract][Full Text] [Related]
5. The effect of valproic acid on blood loss in patients with cerebral palsy.
Chambers HG; Weinstein CH; Mubarak SJ; Wenger DR; Silva PD
J Pediatr Orthop; 1999; 19(6):792-5. PubMed ID: 10573351
[TBL] [Abstract][Full Text] [Related]
6. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.
Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A
Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068
[TBL] [Abstract][Full Text] [Related]
7. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
Lackmann GM
Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
[TBL] [Abstract][Full Text] [Related]
8. Hallucinations after withdrawal of valproic acid.
de Laat SA; Hillegers MH; Jansen FE; Braun KP; de Graeff-Meeder ER
Pediatrics; 2012 Jul; 130(1):e236-8. PubMed ID: 22689876
[TBL] [Abstract][Full Text] [Related]
9. Carnitine deficiency during valproic acid treatment.
Van Wouwe JP
Int J Vitam Nutr Res; 1995; 65(3):211-4. PubMed ID: 8830002
[TBL] [Abstract][Full Text] [Related]
10. Subclinical hypothyroidism during valproic acid therapy in children and adolescents with epilepsy.
Kim SH; Chung HR; Kim SH; Kim H; Lim BC; Chae JH; Kim KJ; Hwang YS; Hwang H
Neuropediatrics; 2012 Jun; 43(3):135-9. PubMed ID: 22618302
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid monotherapy induces DNA oxidative damage.
Schulpis KH; Lazaropoulou C; Regoutas S; Karikas GA; Margeli A; Tsakiris S; Papassotiriou I
Toxicology; 2006 Jan; 217(2-3):228-32. PubMed ID: 16289809
[TBL] [Abstract][Full Text] [Related]
12. Factor VII deficiency associated with valproate treatment.
Unalp A; Dirik E; Kurul S
Pediatr Int; 2008 Jun; 50(3):403-5. PubMed ID: 18533961
[No Abstract] [Full Text] [Related]
13. Risk factors for valproic acid resistance in childhood absence epilepsy.
Ollivier ML; Dubois MF; Krajinovic M; Cossette P; Carmant L
Seizure; 2009 Dec; 18(10):690-4. PubMed ID: 19836978
[TBL] [Abstract][Full Text] [Related]
14. Analysis of acylcarnitine levels by tandem mass spectrometry in epileptic children receiving valproate and oxcarbazepine.
Cansu A; Serdaroglu A; Biberoglu G; Tumer L; Hirfanoglu TL; Ezgu FS; Hasanoglu A
Epileptic Disord; 2011 Dec; 13(4):394-400. PubMed ID: 22258044
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress in children receiving valproic acid.
Michoulas A; Tong V; Teng XW; Chang TK; Abbott FS; Farrell K
J Pediatr; 2006 Nov; 149(5):692-6. PubMed ID: 17095346
[TBL] [Abstract][Full Text] [Related]
16. Hematologic manifestations and impaired liver synthetic function during valproate monotherapy.
Hauser E; Seidl R; Freilinger M; Male C; Herkner K
Brain Dev; 1996; 18(2):105-9. PubMed ID: 8733899
[TBL] [Abstract][Full Text] [Related]
17. Valproate-induced thrombocytopenia: a prospective monotherapy study.
Nasreddine W; Beydoun A
Epilepsia; 2008 Mar; 49(3):438-45. PubMed ID: 18031547
[TBL] [Abstract][Full Text] [Related]
18. Acquired von Willebrand syndrome as side effect of valproic acid therapy in children is rare.
Eberl W; Budde U; Bentele K; Christen HJ; Knapp R; Mey A; Schneppenheim R
Hamostaseologie; 2009 May; 29(2):137-42. PubMed ID: 19404518
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid and thrombocytopenia: cross-sectional study.
Ko CH; Kong CK; Tse PW
Hong Kong Med J; 2001 Mar; 7(1):15-21. PubMed ID: 11406671
[TBL] [Abstract][Full Text] [Related]
20. Acute hemorrhagic pancreatitis due to the use of valproic acid in a child.
Ozaydin E; Yükselgüngör H; Köse G
Eur J Paediatr Neurol; 2008 Mar; 12(2):141-3. PubMed ID: 17881258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
